CTOR - Citius Oncology, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.77 -0.05 (-2.82%)	---	---	---	-0.01 (-0.56%)	-0.03 (-1.71%)	---	-0.01 (-0.56%)

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.08
Diluted EPS:: -0.08
Basic P/E:: -21.5
Diluted P/E:: -21.5
RSI(14) 1m:: 62.5
VWAP:: 1.72
RVol:: 0.2751

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.7 -0.05 (-2.69%)	Oct 15 15:16
1m	Price decrease 1m	1.7 -0.06 (-3.41%)	Oct 15 11:54
10m	Price decrease 10m	1.7 -0.06 (-3.41%)	Oct 15 11:54
1m	Price increase 1m	1.81 +0.06 (+3.43%)	Oct 15 09:30
10m	Price increase 10m	1.81 +0.06 (+3.43%)	Oct 15 09:30